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ABSTRACT 
 Pattern analysis of tandem repeats in gene is an indispensable computational approach to the understanding of 
the gene expression and pathogenesis of diseases.  This research applied a computational motif model and 
database techniques to study the distribution of tandem repeats in Nlrp1 gene, which is a critical gene to detect 
the invading pathogens in the immunologic mechanisms.  The frequency of tandem repeats in Nlrp1 gene was 
studied for mono-, di-, tri-, and tetranucleotides.  Mutations of Nlrp1 gene were analyzed to identify the insertion, 
deletion, and substitution of nucleotides.  The results of this research provide a basis for future work in 
computational drug design and biomedical engineering in tackling diseases associated with immune system.   
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1.     INTRODUCTION    
Tandem repeats are a stretch of nucleotides that repeat in a 
consecutive manner. They are ubiquitous in genome and their 
mutated forms are responsible for diseases [1].  Understanding 
of the patterns of tandem repeat may provide insights into the 
pathogenesis and gene expression patterns. The advancement 
of computational tools such as computer algorithms, databases 
and web servers provide an efficient avenue to analyze 
enormous volume of genetic data, such as the phenomenon of 
tandem repeat in large genome. 
 
This research aims at analyzing the patterns of tandem repeat 
in Nlrp1 gene. This gene is known to play a critical role in 
immune system of human [2]. Its protein product, which is 
NLRP1 inflammasome, can detect bacteria and toxins in a 
signaling pathway that leads to the release of pro-inflammatory 
cytokines [3].  NLRP1 consists of an N-terminal pyrin domain 
(PYD), a central NATCH domain, a leucine-rich repeat 
domain (LRR), a FIIND and a CARD domain [4].  The release 
of the pro-inflammatory cytokines which is mediated by 
inflammasome triggers adaptive immune response to eliminate 
the invading pathogens. The study of the patterns of tandem 
repeats may provide insights into therapeutic strategies related 
to immunologic diseases.   
2.       METHODS 
The nucleotide sequence of Nlrp1 gene was obtained from the 
GenBank of the National Center for Biotechnology 
Information.  UCSC genome browser [5] was used to locate 
the locus of Nlrp1 on the chromosome.  Besides, KEGG 
database [6] was used to extract the signaling pathways for 
Nlrp1 encoded inflammasome.  The statistically expected 
tandem repeats were calculated based on mreps algorithm [7].  
The motif model [8] was constructed by distinguishing non-
motif from tandem repeat motif, as shown below. 
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where BΘ is non-motif and MΘ is motif.  Let Sij be the 
subsequence of length W at position j in a sequence i.  Let a be 
the symbol that occurs at a position k (1 Wk ≤≤ ) of either 
MΘ  or BΘ .  Given that L is a non-empty set for the length of 
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nucleotide sequence, the conditional probabilities that Sij is 
found using the motif model are [8]: 
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We derive the conditional probabilities that Sij to be found 
using the non-motif model from [8]: 
 
PB(Sij) = ∏∏
=
=
=
−+
L
a
aSIB
a
W
k
kji
1
)(
0
1
1,)(θ  (3) 
 
We calculated the motif occurrence probability Z at position j 
in sequence i using formula (4), where λ  is the prior 
probability of motif occurrence [8]. 
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Sij is taken to be a genuine motif hit when the equation (5) is 
fulfilled [8], as shown below. 
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Importantly, due to the complexity of motif, the pseudo-count 
of motif is likely to happen in a gene.  We identified pseudo-
count as below [8]: 
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where Pa/b is the BLOSUM substitution probability for amino 
acid a from the observed amino acid b.  Pseudo-count of motif 
will be excluded from the final results.  For the identified 
tandem repeats, relative frequency was used to analyze the 
total repeat per 100 bases in the nucleotide sequence of Nlrp1 
gene.  Besides, COSMIC database [21] was used to mine the 
mutation information for Nlrp1 gene. 
3.      RESULTS AND DISCUSSION 
Nlrp1 gene has a length of 5623 base pairs (bp) with an even 
distribution of nucleotide composition (A=23.97%, 
T=21.16%, G=26.96%, C=27.90%).  It is located on 
chromosome 17, as shown in Figure. 1 below. 
 
 
Figure. 1: Nlrp1 gene on chromosome 17 
 
The bottom panel of Figure 1 demonstrates that there are 
extensive repeating elements in Nlrp1.  We found that there 
are altogether 336 tandem repeats (in the form of mono-, di-, 
tri-, and tetranucleotide) on the gene.  A total of 190 bp of 
interspersed repeats were found, amounting to 3.38% of the 
total nucleotides.  The frequency of mono-, di-, tri-, and 
tetranucleotide tandem repeats is given in Table 1. 
 
Table 1: The frequency of tandem repeats in Nlrp1 gene 
Tandem repeat Occurrence frequency Relative frequency 
Mononucleotide 
 
Dinucleotide 
90 
 
187 
1.60 
 
3.33 
 
Trinucleotide 
 
Tetranucleotide 
 
51 
 
8 
 
0.91 
 
0.14 
 
We also analyzed the distribution of tandem repeats on Nlrp1 
gene, using a window size of 1000 bp.  The distribution 
pattern is shown in Table 2. Where the sequence repeats were 
found spanning across the window (e.g., start locus at 999, end 
locus at 1004 for a GA repeat), such repeats are categorized 
according to the maximal nucleotide number.  For example, in 
the case where a dinucleotide GA tandem repeats are spanning 
from loci 999 to 1004, they will be categorized under the 
window 1-2kbp.  We observed a somehow even distribution of 
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tandem repeats across the loci of Nlrp1 gene, as shown in 
Table 2.  The number of tandem repeats at the last locus 
window (>5kbp) is lower than other regions primarily because 
the nucleotide length for this region is shorter (only 623 bp) 
than other gene region (1000 bp).  
 
Table 2: The distribution of tandem repeats (occurrence 
frequency) 
Repeats <1kbp 1-2kbp 2-3kbp 3-4kbp 4-5kbp >5kb
p 
Mono- 
 
Di- 
 
Tri- 
 
Tetra- 
19 
 
28 
 
13 
 
2 
20 
 
32 
 
12 
 
1 
13 
 
35 
 
13 
 
1 
9 
 
37 
 
6 
 
1 
11 
 
38 
 
3 
 
2 
18 
 
17 
 
4 
 
1 
 
Total 62 65 62 53 54 40 
 
Though dinucleotide tandem repeats are the most abundant 
repeat type in Nlrp1 gene, the CG tandem repeat was not 
found.  The CG/GC repeat has a frequency of 5 occurrences 
(2.67%) in the total of 187 dinucleotide tandem repeats, which 
is quite low as compared to the percentage of CG/GC 
(64.74%) in the total dinucleotide tandem repeats in Herpes 
simplex virus type 1 (HSV-1) genome [9].  However, the 
percentage of AG/GA occurrence in our study is 33.16%, 
whereas it was reported 4.78% in HSV-1 genome [9].  We also 
found a high percentage of CT/TC (28.88%) in Nlrp1 gene, 
while it was reported a low percentage (3.78%) in HSV-1 
genome [9].  These variations in the abundance level of 
dinucleotide tandem repeats demonstrate the diverging genetic 
characteristics between human and viruses.  
 
Besides, the abundance level and distribution of 
mononucleotide, trinucleotide and tetranucleotide tandem 
repeats in Nlrp1 gene are dissimilar to the findings observed in 
HSV-1 genome [9].  Because Ouyang et al. [9] used a 
measurement of per 1000 bp for the relative frequency (due to 
the larger genome size), and we used a measurement of per 
100 bp (for small gene size), we converted Ouyang et al.’s 
relative frequency to our measurement unit for the purpose of 
comparison.  In Ouyang et al’s findings [9], the relative 
frequency is 0.436, 0.121, and 0.013 for mono-, tri-, and 
tetranucleotide tandem repeats, respectively.  Ouyang et al’s 
results showed that the occurrence of these tandem repeats is 
much lower in the genome of HSV-1 than in human Nlrp1 
gene.  Higher relative frequency of tandem repeat implies that 
the gene is more predisposed to the risk of mutation in the 
region of tandem repeat, therefore exposed to the phenotypic 
changes such as diseases.  
 
We observed 25 tandem repeats which occur in the order 
higher than 4, as listed in Table 3. 
 
 
Table 3: The tandem repeats occur in the order >4 
Repeat motif Start locus End locus 
(C)5 
(C)5 
(C)5 
(C)5 
(C)5 
(C)5 
(C)5 
(G)5 
(G)5 
(G)5 
(G)5 
(G)5 
(T)5 
(T)6 
(A)5 
(A)5 
(A)5 
(A)7 
(A)5 
(A)5 
(A)7 
(A)6 
(A)6 
(A)11 
(AG)6 
384 
524 
1082 
1249 
1276 
4193 
4390 
1554 
1607 
2598 
4075 
5151 
5504 
5535 
1363 
1382 
2168 
2297 
4948 
5530 
5558 
5568 
5575 
5613 
1219 
388 
528 
1086 
1253 
1280 
4197 
4394 
1558 
1611 
2602 
4079 
5155 
5508 
5540 
1367 
1386 
2172 
2303 
4952 
5534 
5564 
5573 
5580 
5623 
1230 
 
From Table 3, all but one tandem repeats occur in the order 
higher than 4 are mononucleotide.  The distribution pattern of 
high order tandem repeats is given in Table 4. 
 
Table 4: The distribution of high order (>4) tandem repeats 
Order  <1kbp 1-2kbp 2-3kbp 3-4kbp 4-5kbp >5kb
p 
5 
6 
7 
>7 
2 
0 
0 
0 
7 
1 
0 
0 
2 
0 
1 
0 
0 
0 
0 
0 
4 
0 
0 
0 
3 
3 
1 
1 
Total 2 8 3 0 4 8 
 
We observed that most of the high order tandem repeats occur 
at loci region 1-2kbp and region >5kbp.  These two regions are 
at the vicinity of 5’ and 3’ terminal region, mutation of which 
may have impacts on the transcriptional specificity (i.e., the 
binding affinity of transcription factors, RNA polymerases and 
enhancers).  The observed mutations may either result in 
overexpression or down-regulation of a gene product [10-14].  
The aberration in gene transcription and mutation in the exons 
may lead to diseases such as cancer and other intractable 
disorders [15-19].  However, the order of tandem repeats 
observed in Nlrp1 is far lesser than the repeat length observed 
in larger genetic region (e.g., chromosomes), where the tandem 
repeats can occur between different genes.  Astolfi et al. [20] 
have reported the occurrence of tandem repeats in the order of 
greater than 50, such as (ACC)82 and (ATC)175 in human 
chromosome 22. 
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We used COSMIC database [21] to mine the mutation 
information for Nlrp1 gene.  There were no deletion and 
insertion mutation found for Nlrp1 gene, yet the substitution 
mutations are quite extensive.  Figure 2 illustrates the 
distribution of point substitution mutation for coding strand in 
Nlrp1 gene. 
 
 
Figure. 2: point substitution mutation in Nlrp1 
 
Figure 2 shows that a total of 32 mutant samples were found in 
Nlrp1 gene, among which the highest rate of mutation type 
being G>A nucleotide substitution (34.29%).  C>T nucleotide 
substitution (22.86%) ranked the second highest rate of 
mutation type, followed with G>T substitution (11.43%).  In 
addition, our analysis on the point substitution mutation for 
both coding and template strands demonstrated that C:G>T:A 
is the most common nucleotide substitution (57.14%), whereas 
C:G>G:C is the least common (2.86%).  Mutation may result 
in aberration or loss-of-function in the gene [22-25], 
consequently results in the change of phenotype.  Mutation in 
gene may culminate in various intractable diseases such as 
cancers [26-29], neurological diseases [30-31], coronary 
disease [32], infectious diseases [33-34], and developmental 
disorders [35].  Functional analysis on the mutation and its 
association to the tandem repeats should be carried out in 
future to understand the impact of polymorphism of tandem 
repeat on the gene expression. 
4.       CONCLUSION 
Nlrp1 gene is known to play an essential role in immune 
system of human, aberration of which may lead to the 
dysregulation of pathogen sensing and diseases.  This research 
has adopted a computational approach to investigate the 
patterns of tandem repeats in Nlrp1 gene.  We observed a 
somehow even distribution of tandem repeats across the loci of 
Nlrp1 gene.  Despite dinucleotide tandem repeats are the most 
abundant repeat type in Nlrp1 gene, the CG tandem repeat was 
not found.  We used COSMIC database to mine the mutation 
information for Nlrp1 gene.  The retrieved data show that there 
were no deletion and insertion mutation, while the substitution 
mutations are quite extensive in Nlrp1 gene.  The results of 
this study provide insights for the computational drug design 
in pharmaceutical industry. 
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